Investor Relations
Bursa Announcements
Stock Name / Code :
PHARMA ( 7081 )
Year :
2024
2023
2022
2021
2020
Archives
Select date range :
News Type :
Category
Additional Listing Announcement
Annual Audited Accounts
Annual Reports
Change of Corporate Information
Changes in Shareholdings
Circulars/Notice to Shareholders
Dealings in Listed Securities (Chapter 14 of Listing Requirements)
Delisting of Securities
Disclosure On Quarterly Production
Entitlements
Expiry / Maturity / Termination of Securities
Financial Results
General Announcement
General Meetings
Important Relevant Dates for Renounceable Rights
Investor Alert
IPO Announcement/LEAP Market Announcement
Listing Circulars
Listing Information and Profile
Prospectus
Reply to Query
Shares Buy Back
Special Announcements
Take-over Offer
Transfer of Listing
Unusual Market Activity
Monday - 4 Mar 2024
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT
Thursday - 29 Feb 2024
Change in Boardroom - DATO MOHD ZAHIR BIN ZAHUR HUSSAIN
Change in Boardroom - DATO' DR FARIDAH ARYANI BINTI MD YUSOF
Change in Boardroom - TUAN DRS. IMAM FATHORRAHMAN
Change in Boardroom - ENCIK ZULKIFLI BIN JAFAR
Quarterly rpt on consolidated results for the financial period ended 31 Dec 2023
Friday - 23 Feb 2024
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : REGULARISATION PLAN
Monday - 19 Feb 2024
Change in Boardroom - PUAN DAYANA ROGAYAH BINTI OMAR
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : REGULARISATION PLAN
Thursday - 1 Feb 2024
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT
Thursday - 4 Jan 2024
OTHERS
CONCESSION AGREEMENT BETWEEN PHARMANIAGA LOGISTICS SDN BHD AND GOVERNMENT OF MALAYSIA (REPRESENTED BY THE MINISTRY OF HEALTH OF MALAYSIA) (Announcement pursuant to Chapter 9 of Bursa Malaysia Securities Berhad Main Market Listing Requirements)
Tuesday - 2 Jan 2024
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT
Friday - 1 Dec 2023
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT
Wednesday - 29 Nov 2023
Quarterly rpt on consolidated results for the financial period ended 30 Sep 2023
PRACTICE NOTE 17 / GUIDANCE NOTE 3 : REGULARISATION PLAN
«
1
2
3
4
5
6
7
8
9
10
»